Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer
Gary Beale(Epistem (United Kingdom)), Céline Cano(Newcastle University), Ian R. Hardcastle(Cancer Research UK), Lan-Zhen Wang(Newcastle University), Huw D. Thomas(Newcastle University), Charlotte Revill(Newcastle University), Emma J. Haagensen(Newcastle University), Roger J. Griffin(Newcastle University), Bernard T. Golding(Newcastle University), David R. Newell(Newcastle University), Sara L. Payne(Newcastle University)
Cited by 61
Related Papers
Tumour necrosis factor in man: Clinical and biological observations
|British Journal of Cancer|1987|203
The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease
|Gastroenterology|2008|196
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
|British Journal of Cancer|2011|193
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
|BMC Cancer|2008|125
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
|British Journal of Cancer|2012|83